Urea Cycle Disorders: Clinical Trials

3 trials for Urea Cycle Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Urea Cycle Disorders: new trials by email Literature Review of Urea Cycle Disorders trials Research Report on Urea Cycle Disorders

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)
HPN-100 - Urea Cycle Disorders
Phase 3CompletedAmgen232011-07-012024-07-11
Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
HPN-100 - Urea Cycle Disorders
Phase 3CompletedAmgen602009-11-012024-07-10
Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders
HPN-100, Buphenyl (NaPBA) - Urea Cycle Disorders
Phase 3CompletedAmgen462009-10-012024-07-09

Narrower conditions

Hyperammonemia (3)  ·  Urea Cycle Disorders, Inborn (3)

Broader conditions

Amino Acid Metabolism, Inborn Errors (3)  ·  Brain Diseases (3)  ·  Brain Diseases, Metabolic (3)  ·  Brain Diseases, Metabolic, Inborn (3)  ·  Central Nervous System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Metabolic Diseases (3)  ·  Metabolism, Inborn Errors (3)  ·  Nervous System Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)

Interventions

glycerol phenylbutyrate (3)  ·  4-phenylbutyric acid (1)

Sponsors

Amgen (3)

Countries

United States (3)  ·  Canada (2)

Results publications

PMID 24144944, PMID 22961727, PMID 23324524